PCOS Rebranded as PMOS: A New Era for Women's Health

Polyendocrine Metabolic Ovarian Syndrome (PMOS), formerly known as Polycystic Ovary Syndrome (PCOS), has been officially recognized as a more accurate representation of this chronic hormonal disorder affecting 170 million women worldwide. The new name, announced at the European Congress of Endocrinology, highlights the conditions impact on multiple hormone glands and associated metabolic problems. PMOS is diagnosed based on two out of three signs: irregular periods, excess testosterone, or numerous ovarian follicles. The rebrand aims to improve diagnosis, treatment, and awareness of the conditions various symptoms, including infertility, thinning hair, mental health issues, and increased risks for obesity, heart disease, diabetes...